• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于维生素D类似物选择性作用的机制

On the mechanisms for the selective action of vitamin D analogs.

作者信息

Dusso A S, Negrea L, Gunawardhana S, Lopez-Hilker S, Finch J, Mori T, Nishii Y, Slatopolsky E, Brown A J

机构信息

Department of Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

出版信息

Endocrinology. 1991 Apr;128(4):1687-92. doi: 10.1210/endo-128-4-1687.

DOI:10.1210/endo-128-4-1687
PMID:2004595
Abstract

A variety of analogs of 1,25-(OH)2D3 with less calcemic activity and lower receptor binding affinity than 1,25-(OH)2D3 have been developed. However, these compounds have equal or greater ability to differentiate leukemia cells and psoriatic fibroblasts and to suppress PTH synthesis and secretion. The mechanism for this selectivity has not been elucidated. Because the lower potency of ergocalciferol compared to cholecalciferol in preventing or curing rickets in chicks was associated with a lower affinity of the avian vitamin D binding protein (DBP) for vitamin D2, we tested five analogs with low calcemic activity including 22-oxa-1,25-(OH)2D3 (OCT), MC903, 1,25-(OH)2-16 ene-23-yne D3, 1,25-(OH)2-26,27 dihomo-22-ene-D3, and 1,25-(OH)2-24-trihomo-22-ene-D3 for their affinity for rat serum DBP. All analogs had a low affinity for DBP, ranging from 50-3000 times less than that of 1,25-(OH)2D3. OCT also bound with low affinity to dog and human serum DBP. We tested with OCT the possible consequences of its low affinity for serum DBP. One of the functions of DBP is to prolong the lifetime of 1,25-(OH)2D3 in circulation. Quantification of the metabolic clearance rate (MCR) of OCT in 8 normal dogs using a single bolus injection technique showed that OCT was cleared at a rate of 48.2 +/- 7.5 ml/min, approximately 6-7 times more rapidly than 1,25-(OH)2D3 (6.8 +/- 0.4 ml/min). The estimated half-life of OCT in the circulation was 2.5 +/- 0.3 h compared to 7.0 +/- 0.6; n = 7 for 1,25-(OH)2D3. As our primary interest is the potential of OCT in treating the secondary hyperparathyroidism of CRF, we also measured the MCR of OCT in 5/6 nephrectomized dogs. Uremia does not affect the rate of clearance of OCT from the circulation (MCR: 56.8 +/- 4.5; t1/2 = 2.1 +/- 0.2 n = 4). Despite its shorter half-life, OCT suppressed PTH secretion in vivo in uremic dogs. The effects of low binding to DBP on the percentage uremic dogs. The effects of low binding to DBP on the percentage of free sterol were determined using an ultrafiltration procedure. We compared the proportion of free (unbound) OCT and 1,25-(OH)2D3 in 0.1% BSA-PBS with concentrations of human serum ranging from 0-25%. The proportion of OCT in the free form was significantly higher than that of 1,25-(OH)2D3 for every serum concentration tested. The physiological relevance of a higher percentage of free OCT was tested in normal human macrophages.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

已研发出多种1,25-(OH)₂D₃类似物,其血钙活性低于1,25-(OH)₂D₃,与受体的结合亲和力也较低。然而,这些化合物在分化白血病细胞和银屑病成纤维细胞以及抑制甲状旁腺激素(PTH)合成与分泌方面具有相同或更强的能力。这种选择性的机制尚未阐明。由于与胆钙化醇相比,麦角钙化醇在预防或治愈雏鸡佝偻病方面效力较低,这与禽类维生素D结合蛋白(DBP)对维生素D₂的亲和力较低有关,因此我们测试了五种低血钙活性的类似物,包括22-氧杂-1,25-(OH)₂D₃(OCT)、MC903、1,25-(OH)₂-16-烯-23-炔-D₃、1,25-(OH)₂-26,27-二高-22-烯-D₃和1,25-(OH)₂-24-三高-22-烯-D₃对大鼠血清DBP的亲和力。所有类似物对DBP的亲和力都很低,比1,25-(OH)₂D₃低50至3000倍。OCT与犬和人血清DBP的结合亲和力也很低。我们用OCT测试了其对血清DBP低亲和力可能产生的后果。DBP的功能之一是延长1,25-(OH)₂D₃在循环中的半衰期。采用单次大剂量注射技术对8只正常犬体内OCT的代谢清除率(MCR)进行定量分析,结果显示OCT的清除速率为48.2±7.5 ml/min,约为1,25-(OH)₂D₃(6.8±0.4 ml/min)的6至7倍。OCT在循环中的估计半衰期为2.5±0.3小时,而1,25-(OH)₂D₃为7.0±0.6小时;1,25-(OH)₂D₃的n = 7。由于我们主要关注OCT治疗慢性肾衰竭继发性甲状旁腺功能亢进的潜力,因此我们也测量了5/6肾切除犬体内OCT的MCR。尿毒症不影响OCT从循环中的清除速率(MCR:56.8±4.5;t₁/₂ = 2.1±0.2,n = 4)。尽管OCT半衰期较短,但它在体内可抑制尿毒症犬的PTH分泌。采用超滤法测定DBP低结合对尿毒症犬游离甾醇百分比的影响。我们比较了在含0.1%牛血清白蛋白(BSA)的磷酸盐缓冲液(PBS)中,人血清浓度为0至25%时游离(未结合)OCT和1,25-(OH)₂D₃的比例。对于所测试的每种血清浓度,游离形式的OCT比例均显著高于1,25-(OH)₂D₃。在正常人类巨噬细胞中测试了较高百分比的游离OCT的生理相关性。(摘要截选至400字)

相似文献

1
On the mechanisms for the selective action of vitamin D analogs.关于维生素D类似物选择性作用的机制
Endocrinology. 1991 Apr;128(4):1687-92. doi: 10.1210/endo-128-4-1687.
2
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
3
Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity.对维生素D结合蛋白亲和力低的维生素D类似物:体外活性增强而体内活性降低。
J Bone Miner Res. 1991 Oct;6(10):1051-7. doi: 10.1002/jbmr.5650061006.
4
Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.维生素D3类似物对人前列腺癌细胞系的作用:与1,25 - 二羟维生素D3的比较
Endocrinology. 1995 Jan;136(1):20-6. doi: 10.1210/endo.136.1.7530193.
5
The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.22-氧杂骨化三醇在成骨样(ROS 17/2.8)细胞中的活性。
Endocrinology. 1991 Aug;129(2):778-84. doi: 10.1210/endo-129-2-778.
6
Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.维生素D类似物2-亚甲基-19-去甲-(20S)-1α-羟基双高麦角钙化醇(2MbisP)对继发性甲状旁腺功能亢进的影响。
J Bone Miner Res. 2007 May;22(5):686-94. doi: 10.1359/jbmr.070202.
7
The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion.维生素D的非钙调节类似物,22-氧杂骨化三醇,可抑制甲状旁腺激素的合成与分泌。
J Clin Invest. 1989 Sep;84(3):728-32. doi: 10.1172/JCI114229.
8
The mechanism for the disparate actions of calcitriol and 22-oxacalcitriol in the intestine.骨化三醇和22-氧杂骨化三醇在肠道中不同作用的机制。
Endocrinology. 1993 Sep;133(3):1158-64. doi: 10.1210/endo.133.3.8396012.
9
Abnormal expression and regulation of vitamin D receptor in experimental uremia.实验性尿毒症中维生素D受体的异常表达与调控
Nephron. 1996;73(4):619-28. doi: 10.1159/000189150.
10
1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.1,25(OH)2-16-烯维生素D3是一种强效抗白血病药物,引起高钙血症的可能性较低。
Leuk Res. 1994 Jun;18(6):453-63. doi: 10.1016/0145-2126(94)90081-7.

引用本文的文献

1
Non-classical Vitamin D Actions for Renal Protection.非经典维生素D对肾脏的保护作用。
Front Med (Lausanne). 2021 Dec 7;8:790513. doi: 10.3389/fmed.2021.790513. eCollection 2021.
2
Vitamin D as a Potential Therapy for Multiple Sclerosis: Where Are We?维生素 D 作为多发性硬化症的一种潜在疗法:我们在哪里?
Int J Mol Sci. 2020 Apr 28;21(9):3102. doi: 10.3390/ijms21093102.
3
Rationale to reduce calcium intake in adult patients with chronic kidney disease.减少慢性肾脏病成年患者钙摄入量的理由。
Curr Opin Nephrol Hypertens. 2018 Jul;27(4):251-257. doi: 10.1097/MNH.0000000000000416.
4
Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG.维生素D受体激活可减少VCaP异种移植瘤的生长,并抵消ERG活性,尽管会诱导TMPRSS2:ERG。
Oncotarget. 2017 Jul 4;8(27):44447-44464. doi: 10.18632/oncotarget.17968.
5
The role of vitamin D in the endocrinology controlling calcium homeostasis.维生素D在控制钙稳态的内分泌学中的作用。
Mol Cell Endocrinol. 2017 Sep 15;453:36-45. doi: 10.1016/j.mce.2017.04.008. Epub 2017 Apr 9.
6
Vitamin D receptor gene polymorphism in children with urinary tract infection.维生素 D 受体基因多态性与儿童尿路感染的关系。
Pediatr Nephrol. 2012 Mar;27(3):417-21. doi: 10.1007/s00467-011-2000-0. Epub 2011 Sep 25.
7
Hypovitaminosis D as predisposing factor for atrophic type A gastritis: a case-control study and review of the literature on the interaction of Vitamin D with the immune system.维生素 D 缺乏作为萎缩性 A 型胃炎的诱发因素:病例对照研究及维生素 D 与免疫系统相互作用的文献复习。
Clin Rev Allergy Immunol. 2012 Jun;42(3):355-64. doi: 10.1007/s12016-011-8255-1.
8
Pharmacokinetic studies of vitamin D analogues: relationship to vitamin D binding protein (DBP).
Endocrine. 1995 Apr;3(4):263-6. doi: 10.1007/BF03021403.
9
Vitamin D and its analogs in chronic renal failure.维生素D及其类似物与慢性肾衰竭
Osteoporos Int. 1997;7 Suppl 3:S202-8. doi: 10.1007/BF03194373.
10
Conformational change and enhanced stabilization of the vitamin D receptor by the 1,25-dihydroxyvitamin D3 analog KH1060.1,25 - 二羟基维生素D3类似物KH1060引起维生素D受体的构象变化及稳定性增强
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10685-90. doi: 10.1073/pnas.93.20.10685.